EM2004H "Mechanical Ventilation in COVID-19 Disease – Controversial or not?" (IM GR-042420)
Since the beginning of 2020 when the SARS-CoV-2 pandemic began to spread worldwide, we have rushed headlong in our search for mechanisms of disease and therapeutic interventions. This presentation will sift through the available reports in the management of respiratory failure secondary to COVID-19 with a grounding in respiratory physiology and accepted studies of pre-pandemic ARDS treatments. The challenges in managing an evolving disease in the social media era will be discussed.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Discuss the heterogenous mechanisms of ARDS pathophysiology
- List the accepted standard-of-care supporting treatments for ARDS before the SARS-CoV-2 pandemic.
- Contrast the differences between research-supported interventions for COVID 19 respiratory failure and those proffered via social media reports and biased real-time conjecture, while appreciating the difficulty of managing a disease evolving in real time.
Corey Kershaw, M.D.
Associate Professor, Department of Internal Medicine
Division of Pulmonary & Critical Care Medicine
Medical Director, Clements University Hospital, MICU
- 1.00 AMA